NMRA: Neumora Therapeutics Inc

1.73 USD 0.03 (1.70%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do NMRA para hoje mudou para -1.70%. Paralelamente, o preço mais baixo no mercado atingiu 1.71 e o mais alto foi 1.76.

Veja a dinâmica do par de moedas Neumora Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

NMRA Notícias

14:46 Stifel maintains Hold rating on Neumora Therapeutics stock at $2.00
06:41 Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call Transcript
23:46 Neumora (NMRA) Q2 Loss Improves 10%
14:31 Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday - Aon (NYSE:AON), Bel Fuse (NASDAQ:BELFA)
11:05 Neumora Therapeutics soars 68% following InvestingPro’s June Fair Value signal
10:40 Mizuho raises Neumora Therapeutics stock price target on new drug candidate
11:41 H.C. Wainwright reiterates Buy rating on Neumora Therapeutics stock
11:04 Neumora begins phase 1 trial of schizophrenia drug NMRA-861
20:12 NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
18:12 ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
16:36 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
14:03 Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy' - Johnson & Johnson (NYSE:JNJ)
17:45 Neumora Therapeutics shares fall as company adjusts depression drug trials
16:37 Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call Transcript

Faixa diária

1.71 1.76

Faixa anual

0.61 17.19

Fechamento anterior: 1.76
Open: 1.75

Bid: 1.73
Ask: 2.03

Low: 1.71
High: 1.76

Volume: 209

Mudança diária: -1.70%
Mudança mensal: -7.98%

Mudança de 6 meses: 6.79%
Mudança anual: -84.64%

31 agosto, domingo